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AbstrAct
Objectives  To assess the occurrence of glaucoma, eyelid, 
corneal and macular disorders in a cohort of patients with 
obstructive sleep apnoea (OSA) diagnosed by overnight 
polysomnography and to investigate into the risk factors 
for the above eye diseases (EDs).
Design Cross-sectional cohort study between 2014 and 
2015.
setting Unit of Respiratory Medicine and Eye Clinic of the 
University of Verona.
Participants 431 consecutive patients were considered 
eligible. Of these, 87 declined to participate, 35 were 
untraceable and 13 were deceased.
Interventions A complete ophthalmic evaluation of both 
eyes for each patient.
Primary and secondary outcome measures Best-
corrected distance visual acuity, intraocular pressure, 
corneal, macular and optic nerve optical coherence 
tomography, ocular aberrometry, optic nerve laser 
polarimetry, visual field test, and eyelid examination.
results 296 patients aged 64.5±12.8 years, 23% female 
and 77% male, underwent ophthalmic examination. 
There was 56% (n=166) prevalence of eyelid disorders, 
27% (n=80) of corneal disorders, 13% (n=39) of macular 
disorders and 11% (n=33) of glaucoma. Advancing 
age was not associated with the severity of OSA, while 
significant differences were found for gender, body 
mass index, Oxygen Desaturation Index, smoking habit, 
hypertension and diabetes. Severe OSA was significantly 
associated with glaucoma (OR, 95% CI 1.05 to 5.93, 
p=0.037).
conclusions EDs were more prevalent in our patinets 
with OSA than in the general population. Severe Apnoea/
Hypopnoea Index level seemed to play a role as risk factor 
only for glaucoma.
IntrODuctIOn
Obstructive sleep apnoea (OSA), also referred 
to as obstructive sleep apnoea-hypopnoea 
syndrome, is a highly prevalent disorder char-
acterised by repetitive obstruction episodes 
of the upper airway resulting in oxygen desat-
uration, arousals from sleep, and daytime 
symptoms such as excessive sleepiness, poor 
concentration and fatigue.1 Age, gender and 
obesity are recognised as the strongest risk 
factors in OSA.2 Recent data from the USA 
and Europe suggest that 14%–49% of middle-
aged men have clinically significant OSA.3
The diagnosis of OSA requires the 
combined assessment of relevant clinical 
features and the objective demonstration of 
abnormal breathing during sleep. Current 
evidence supports the view that clinical assess-
ment alone does not suffice to make a diag-
nosis, nor does it provide an objective staging 
of clinically significant OSA. Currently over-
night polysomnography (PSG) is the gold 
standard for the diagnosis.
The association between OSA and eye 
diseases (EDs) was first described in 1997 by 
McNab4, who reported OSA in eight patients 
with floppy eyelid syndrome (FES) and FES 
in 1/20 (5%) patients with OSA.In the same 
year, Robert et al5 reported an increased prev-
alence of eyelid laxity in patients with OSA 
requiring treatment for primary open-angle 
glaucoma (POAG).5 Afterwards, the associ-
ation between sleep disorders and EDs was 
increasingly reported.6 Studies in patients 
with OSA determined that 2% had kerato-
conus (KC),7 2%–16% FES,8 2%–20% POAG 
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Research
strengths and limitations of this study
 ► This is a cross-sectional cohort study that provides 
prevalence and risk factors of eye disease in 
patients diagnosed with obstructive sleep apnoea 
using overnight polysomnography.
 ► Each patient had a complete ophthalmic evaluation 
of both eyes.
 ► The study was carried out in a university setting, and 
it was possible that our patients were a subgroup of 
obstructive sleep apnoea population.
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or normal tension glaucoma (NTG),9 and 16% an 
increased risk of developing non-arteritic anterior isch-
aemic optic neuropathy (NAION).10
There is an emerging interest in the epidemiological 
and clinical evidence for an association between OSA and 
EDs. However, due to its implication in diagnostic and ther-
apeutic management, it remains unclear whether there 
are common pathophysiological links and/or the same 
risk factors and/or whether they are accidentally associ-
ated. Studies that investigated into the possibility of there 
being underlying mechanisms have several limitations due 
to selection or observer bias, misclassification of patients, 
sample size or poor statistics. Some of the main weaknesses 
are due to methodological considerations as to the diag-
nostic criteria for OSA and EDs, or from studies that only 
estimated OSA by questionnaire, rather than following 
instrumental diagnostic procedures. Furthermore, no 
studies correlate the severity of OSA with the occurrence 
of EDs.
Therefore, the SLEep apnoea and Eye Pathologies 
studY (SLE.E.P.Y) was set up to estimate the prevalence 
and risk of eyelid disorders, corneal disorders, glaucoma, 
macular and optic nerve disorders in patients diagnosed 
with OSA by PSG.
MethODs
SLE.E.P.Y was a cross-sectional cohort study of adult 
patients diagnosed with OSA assessed for EDs (eyelid disor-
ders, corneal disorders, glaucoma, macular and optic nerve 
disorders) at the University Eye Clinic between 2014 and 
2015. All patients were previously diagnosed with OSA at 
the sleep clinic of the same university following overnight 
PSG because of breathing disorders during sleep and/
or suspected OSA. Any patients suspected of having sleep 
disorders other than OSA (central sleep apnoea, complex 
or mixed sleep apnoea, and patients with craniofacial 
deformations) were excluded. The study was carried out in 
agreement with the tenets of the Declaration of Helsinki. 
Patients’ written informed consent was obtained. Our Insti-
tutional Review Board/ethics committee approved the 
study.
All patients underwent PSG, which lasted a minimum 
of 6 hours. It was started at 23:00 and a portable device 
(Embletta-PSD Somnologica, Sapio Life, Reykjavik, 
Iceland) was used to record nose and mouth airflow, chest 
and abdominal movement, body position, heart rate, 
Oxygen Desaturation Index and snoring time. Prior deter-
mination of whether the patients were appropriate candi-
dates for unattended portable monitoring was performed 
by an experienced clinician, according to the American 
Academy of Sleep Medicine Portable Monitoring Task 
Force.11 Polysomnograms were analysed and Apnoea/
Hypopnoea Index (AHI) was calculated as the number 
of obstructive apnoea episodes (complete cessation of 
airflow for at least 10 s) and of hypopnoea episodes (an 
airflow reduction of >50% for at least 10 s with a decrease 
in oxygen saturation of >3%) despite ongoing inspiratory 
efforts per hour of sleep.12 An AHI of ≥5 events/hour was 
considered suggestive of OSA, defined as mild (5–14), 
moderate (15–30) or severe (>30).
A complete ophthalmic evaluation was carried out for 
each patient, including best-corrected distance visual 
acuity (BCDVA) based on the logMAR chart, and slit lamp 
biomicroscopy of the anterior and posterior segment, 
including intraocular pressure (IOP) using a Goldmann 
applanation tonometer after topical administration of 
oxybuprocaine at 0.4% and fluorescein at 2% with the 
patient in a sitting position. Corneal examination included 
an assessment of apical keratometry, vertical symmetry 
index and surface asymmetry index using corneal 
topography (Eye Top, CSO, Florence, Italy), assessment 
of minimal pachymetry and posterior elevation (PE1 
and PE2) using corneal optical coherence tomography 
(Visante Omni, Carl Zeiss, Oberkochen, Germany), and 
assessment of coma and root mean square using ocular 
aberrometry (KR-1W, Topcon, Tokyo, Japan). An optic 
nerve laser polarimetry (Gdx VCC, Carl Zeiss Meditec, 
Dublin, California, USA) was used to record the nerve 
fibre indicator (NFI). The average thickness of the retinal 
nerve fibre layer (RNFL) of the four quadrants (superior, 
nasal, inferior and temporal) was evaluated by optical 
coherence tomography (Spectralis SD-OCT, Heidelberg 
Engineering, Heidelberg, Germany). Mean deviation and 
pattern SD were calculated by the 30–2 SITA-Standard 
Humphrey Visual Field (VF) test (Carl Zeiss Meditec). 
The VF test was repeated if significant fixation losses and/
or false positives or negatives were >15%. Macular thick-
ness and volume were recorded using optical coherence 
tomography (Spectralis SD-OCT). Eyelid examination 
was performed by evaluating horizontal distraction from 
the ocular globe of the upper and lower eyelids, and the 
easy eversion sign of upper eyelid (easy distortion and 
eversion with minimal superolateral traction).
The presence of abnormal corneal thickness and 
abnormal anterior or posterior ectasia, without corneal 
inflammatory signs, was considered indicative of a corneal 
ectatic disorder according to the Global Delphi Panel 
of Keratoconus and Ectatic Diseases.13 The criteria used 
to define glaucoma were alteration of VF (paracentral 
scotoma, nasal step or altitudinal defects) in absence of 
neurological lesion to explain the VF defect and/or glau-
comatous cupping within the optic disc accompanied by an 
NFI of >50 and/or defects in the RNFL thickness according 
to criteria for early diagnosis.14 The criteria used to define 
macular disorders were non-physiological macular profile, 
a central subfield retinal thickness of >315 µm and a total 
macular volume of >3.19 mm.1 15 16 Diagnosis of any ante-
rior NAION was made following the clinical examination 
of fundus oculi, and the measurement of both the VF and 
of the BCDVA.
A horizontal distraction of >5 mm for the upper lid and 
of >6 mm for the lower lid was considered indicative of 
increased laxity.17 FES was defined as the presence of the 
easy eversion sign of the upper eyelid and the presence of 
large papillae in the same eyelid conjunctiva.18
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Figure 1 Flow diagram of the progress of all participants through the study. AHI, Apnoea/Hypopnoea Index; OSA, obstructive 
sleep apnoea. 
Clinical and instrumental exams were performed by 
experienced ophthalmologists and a blind assessment 
of the results was carried out by two ophthalmologists 
who were not directly involved in patients’ examination. 
A diagnosis of ED was confirmed only when the two 
ophthalmologists were in agreement.
Results for categorical variables were expressed as counts 
and percentages, and the χ2test was used to assess any 
difference in demographics and clinical characteristics 
in terms of AHI levels (mild, moderate and severe OSA) 
in the study group. The individual prevalence of ED was 
evaluated, and the CI calculated through normal approx-
imation interval. Each patient was considered prevalent 
in case of at least one eye being affected. The risk factors 
of ED were calculated by logistic regression analyses. 
The independent variables were gender, age, body mass 
index (BMI), AHI, smoking status and any comorbidities. 
Multivariable model was adjusted for gender, age, BMI 
and hypertension as possible confounders, introduced in 
the model as categorical variables. We performed logistic 
analyses pondering for patient eyes, and multivariable 
logistical regression with clustering was used to calcu-
late the adjusted OR for each of the four study outcomes 
(eyelid disorders, corneal disorders, glaucoma, macular 
and optic nerve disorders). The p value was set at 0.05 
and the CIs calculated at 95%. The Stata V.13 statistical 
software was used to analyse the data.
results
A total of 431 consecutive patients diagnosed with OSA 
were considered eligible for the study. Two hundred 
and ninety-six (69%) underwent ophthalmic examina-
tion (figure 1). Participants did not differ significantly 
from non-participants. The main reason for exclusion 
was refusing to participate. The majority of the patients 
refused due to deambulation difficulties and/or need of 
parents’ assistance. The majority of examined patients 
were male (77%), with mean (SD) and median age of 
62.2 (14.0) and 65.6 years, respectively. Table 1 shows 
patients’ baseline characteristics according to the levels of 
AHI. A total of 233 (79%) patients had least one main ED 
and 50 (21%) of them were under continuous positive 
airway pressure treatment. Of the 296 patients, 32 (11%) 
had both eyelid and corneal disorders, 7 (2%) all EDs 
except NAION, and 3 (1%) were affected by NAION. The 
prevalence of ED is reported in table 2. Patients with KC 
had BCDVA of 1.0 logMAR and 25/33 (75.8%) patients 
with glaucoma had been newly diagnosed. No optic disc 
oedema was observed. Table 3 shows the frequency of 
AHI level for EDs. The multivariable analysis demon-
strated that a severe AHI level was associated to glaucoma.
DIscussIOn
To the best of our knowledge, this study was carried out 
on the largest cohort of patients with OSA diagnosed by 
PSG, evaluated for EDs. It was observed that most of the 
patients with OSA had eye involvement, confirming the 
epidemiology of EDs reported by the literature in this 
group of patients.8 9 13 19 A higher prevalence of OSA 
in male, obese, smoker, hypertension or patients with 
diabetes was also shown, confirming the epidemiology 
reported by the literature.2
Eyelid disorders were observed to be the most frequent 
ED. About 50% of patients had a diagnosis of eyelid hyper-
laxity or FES. It has been hypothesised that hypoxia, reper-
fusion-induced injury and increased level of leptin have a 
causal effect on the development of FES as they lead to an 
upregulation of matrix metalloproteinases (MMPs) and C 
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Table 1 Characteristics of patients according to the severity of OSA (n=592)*
AHI level, events/hour
Exact p
5–14.9
N=180
(n, %)
15–30
N=132
(n, %)
>30
N=280
(n, %)
Gender 0.046
  Female 42 (23.3) 40 (30.3) 54 (19.3)
  Male 138 (76.7) 92 (69.7) 226 (80.7)
Age, years 0.831
  <65 100 (55.6) 66 (50.0) 130 (46.4)
  ≥65 80 (44.4) 66 (50.0) 150 (53.6)
BMI, kg/m2 0.001
  >30 62 (34.4) 58 (43.9) 184 (65.7)
  18–24.9 30 (16.7) 12 (9.1) 12 (4.3)
  25–30 88 (48.9) 62 (47.0) 84 (30.0)
ODI, events/hour 0.001
  0–16 172 (95.6) 56 (42.4) 72 (25.7)
  16.1–31 4 (2.2) 74 (56.1) 200 (71.4)
Smoking habit 0.04
  Ex-smoker 78 (48.1) 64 (54.2) 96 (46.6)
  Current smoker 28 (17.3) 10 (8.5) 46 (22.3)
  Never smoker 56 (34.6) 44 (37.3) 64 (31.1)
  Comorbidities
  Hypertension 76 (42.2) 82 (62.1) 154 (55.0) 0.001
  Heart diseases 48 (26.7) 28 (21.2) 66 (23.6) 0.591
  Respiratory 44 (24.4) 32 (24.2) 48 (17.1) 0.221
  Diabetes 22 (12.2) 26 (19.7) 68 (24.3) 0.001
  Anxiety/depression 22 (12.2) 24 (18.2) 40 (14.3) 0.291
  Endocrinology 12 (6.7) 18 (13.6) 22 (7.9) 0.081
  Cerebrovascular 6 (3.3) 8 (6.1) 16 (5.7) 0.361
  Lower limb arteriopathy 8 (4.4) 8 (6.1) 8 (2.9) 0.351
*Eyes were considered the unit of analysis.
AHI, Apnoea/Hypopnoea Index; BMI, body mass index; ODI, Oxygen Desaturation Index; OSA, obstructive sleep apnoea.
reactive protein.20 An additional possible mechanism may 
involve minor trauma or mechanical stress4 21 due to the 
sleep preference for the involved side and/or nocturnal 
eyelid eversion.22 23 Our study did not find any evidence 
of a higher prevalence of eyelid disorders in patients with 
different AHI levels. Only two previous studies report this 
correlation, although they have a small number of patients 
and only one evaluates patients following the American 
Academy of Sleep Medicine criteria.7 24
The second most frequent ED was corneal disorders. 
The six patients diagnosed with KC accounted for a prev-
alence of 2%, in agreement with Mojon et al.7 This was a 
higher value compared with the 0.054% prevalence in the 
general population.25 Ectasia was also evaluated as a sign 
of early stage of subclinical KC.13 The results from our 
study showed for the first time that ectasia was associated 
with BMI, as expected, and also with the severity of OSA.
It is most likely that the aetiological mechanisms for 
this association are multifactorial. It has been suggested 
that MMPs and proteinase inhibitors may be causative 
factors for developing KC in healthy subject, as they lead 
to a reduction in corneal resistance and corneal hyster-
esis.26 In patients with OSA, the high serum levels and 
activity of MMPs or C reactive protein may well account 
for altered airway biomechanics, leading to repetitive 
collapse of the upper airway.20 27 The recurrence of 
hypoxic conditions may lead to anaerobic glycolysis and 
stromal acidosis, and may promote the transcription of 
proinflammatory cytokines, tumour necrosis factor-α or 
interleukin-6, leading to corneal thinning.28 29 Indeed, 
the systemic low-grade chronic inflammation that affects 
obese patients may contribute to the development of 
corneal ectasia. Our study failed to confirm the hypoxic 
condition as cause of low-grade chronic inflammation 
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Table 2 Prevalence of eye diseases (n=296)
n (%) 95% CI
Eyelid disorders 166 (56.1) 50.4 to 61.7
Eyelid laxity 111 (37.5) 32.0 to 43.0
Floppy eyelid syndrome 55 (18.6) 14.1 to 23.0
Corneal disorders 80 (27.0) 22.0 to 32.1
Ectasia 72 (24.3) 19.4 to 29.2
Keratoconus 6 (2.0) 0.4 to 3.6
Pellucid marginal degeneration 2 (0.7) 0.3 to 1.6
Macular disorders 37 (12.5) 8.7 to 16.3
Epiretinal membrane 21 (7.1) 4.2 to 10.0
Age-related macular 
degeneration
16 (5.4) 2.8 to 8.0
Glaucoma 33 (11.1) 7.6 to 14.7
Normal tension glaucoma 28 (9.5) 6.1 to 12.8
Primary open-angle glaucoma 5 (1.7) 0.2 to 3.2
Non-arteritic anterior ischaemic 
optic neuropathy
3 (1.0) 0.1 to 2.2
Other 11 (3.7) 1.6 to 5.9
Diabetic retinopathy 4 (1.4) 0.0 to 2.7
Cerebral artery stroke 2 (0.7) 0.3 to 1.6
Chorioretinitis 1 (0.3) 0.3 to 1.0
Lenticopathy 1 (0.3) 0.3 to 1.0
Retinal artery occlusion 1 (0.3) 0.3 to 1.0
Retinitis pigmentosa 1 (0.3) 0.3 to 1.0
Trauma 1 (0.3) 0.3 to 1.0
Table 3 Risk factors for eye diseases according to the 
levels of AHI
AHI, 
events/
hour N
Diseased 
eyes, %
Multivariable 
analysis*
OR (95% CI) Exact p
Eyelid disorders
  5–14.9 180 44.0 1.00 –
  15–30 132 52.0 1.27 (0.69 to 2.34) 0.42
  >30 280 57.0 1.45 (0.85 to 2.47) 0.16
Corneal disorders
  5–14.9 180 20.1 1.00 –
  15–30 132 20.5 1.11 (0.51 to 2.40) 0.78
  >30 280 26.0 1.74 (0.90 to 3.46) 0.09
Macular disorders
  5–14.9 180 6.1 1.00 –
  15–30 132 5.3 0.69 (0.25 to 1.90) 0.552
  >30 280 10.4 1.27 (0.53 to 3.06) 0.587
Glaucoma
  5–14.9 180 3.8 1.00 –
  15–30 132 8.3 2.23 (0.78 to 6.39) 0.134
  >30 280 10.0 2.50 (1.05 to 5.93) 0.037
*Logistic model regression with clustering adjusted for sex, age 
and body mass index
AHI, apnoea/hypopnoea index.
since we did not observe a higher prevalence in patients 
with higher AHI levels.
Macular disorders were also investigated and were the 
third most frequent ED in our patients with OSA. It resulted 
in threefold prevalence in our patients with OSA than what 
has been observed in the general population. Despite this 
higher prevalence, we did not find AHI levels as a risk factor 
for age related macular degeneration (AMD). The same 
prevalence of epiretinal membrane did not differ from that 
in the general population.30 31
The fourth most frequently observed ED was glaucoma. 
A large, multicentre, prospective cohort study in France 
does not show a significant influence of OSA diagnosis on 
the risk to develop glaucoma, while age >61.4 years, female 
gender, BMI <30 kg/m2, hypertension, high triglyceride 
levels or thyroid dysfunction are significantly associated 
with increased risk of glaucoma.32 In contrast a meta-anal-
ysis involving 2 288 701 participants shows that OSA is a 
risk factor for glaucoma, higher in Chinese population, 
female or younger population.33 Our study also found an 
increase prevalence in patients with severe AHI, exploring 
the relationship of the severity of OSA, as suggested in this 
meta-analysis. There was no difference in POAG prevalence 
in the general Italian and our study cohort.34 Whereas 
the prevalence for NTG was tenfold (9.5% vs 0.6% in the 
general population), there was also a fivefold increased 
prevalence of glaucoma in our patients with OSA and an 
increased risk of glaucoma, which was statistically signifi-
cantly related to the OSA severity and advancing age. The 
aetiological mechanisms for the association between OSA 
and glaucoma remain to be clarified. Vascular theory postu-
lates patients with OSA have a collapse of the upper airway 
during sleep, leading to repeated and prolonged episodes 
of hypoxia-reperfusion. This may reduce the oxygen supply 
to the optic nerve with subsequent optic neuropathy.35 
Hypoxia may also increase intracranial pressure, which in 
turn may decrease cerebral and optic nerve perfusion.36 
The mechanical theory proposes that OSA has the potential 
to raise the IOP through changes in sleep architecture and 
an increase in sympathetic tone. This increased IOP may 
lead to axon damage of the optic nerve. Other theories, 
such as inflammation and oxidative stress, have also been 
put forward.37 All these theories describe the occurrence of 
optic nerve damage, which does not depend on an increase 
in the IOP and might explain the tenfold increased preva-
lence of NTG observed in our patients with OSA compared 
with the general population. This is also supported by 
a relative risk of 3.34 to have OSA in patients with NTG 
compared with systemic risk factors-matched subjects.38
NAION was the least frequently observed ED. Although 
the underlying pathophysiological mechanisms of NAION 
have not yet been fully elucidated, it has been hypothesised 
that there is a circulatory insufficiency within the optic 
nerve head during a nocturnal non-dipping blood pressure 
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profile promoted by OSA. Indeed, OSA is a risk factor for 
NAION, and it has been reported that patients run a sixfold 
risk of developing NAION than subjects without OSA.39 
Several studies have investigated the increased prevalence 
of OSA in patients with NAION, some showing OSA as a 
risk factor, other as a contributing factor to established 
vascular endothelium defects that can damage autoregu-
lation of optic nerve head blood flow.6 40 41 To the best of 
our knowledge, there is only one study that has previously 
evaluated the prevalence of NAION in an OSA population. 
Moreover, this study uses a large administrative databases 
and not medical records, leading to several limitations.42 
Our study confirmed a twofold prevalence of NAION in 
OSA population compared with the general population.43
To have performed portable monitoring PSG was the 
major limitation of our study. Portable PSG underesti-
mates AHI compared with in-laboratory PSG. However, 
portable PSG is not inferior to in-laboratory PSG for 
a diagnosis of OSA and can be used in the majority of 
patients with suspected sleep apnoea with lower costs.44
In conclusion, our data showed that only glaucoma was 
significantly associated with severe AHI. Therefore, we are 
of the opinion that any previous diagnosis or suspicion of 
OSA should be thoroughly assessed by an ophthalmolo-
gist during ophthalmic examination, due to the implica-
tions in the management of increased eyelid laxity and 
FES, corneal refraction, macular degeneration or, above 
all, glaucoma. Hopefully this report will prompt further 
research on the underlying mechanisms involved in the 
association between EDs and OSA.
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